PRME - Prime Medicine Inc
4.05
-0.060 -1.481%
Share volume: 2,250,167
Last Updated: 03-10-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.11
-0.06
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-10-2024 | 08-08-2024 | 11-12-2024 | 02-28-2025 | 05-08-2025 | 11-07-2025 | 03-03-2026 | |
| Assets | ||||||||
| Total Assets | 311.383 M | 259.705 M | 332.784 M | 297.508 M | 328.163 M | 385.012 M | 342.733 M | |
| Current Assets | 217.654 M | 170.803 M | 246.071 M | 211.886 M | 163.765 M | 231.406 M | 181.293 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 2.728 M | 3.736 M | 9.538 M | 14.667 M | 16.544 M | 15.626 M | 674.000 K | |
| Short Term Investments | 116.561 M | 107.268 M | 57.550 M | 7.966 M | 52.379 M | 141.891 M | 114.648 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 94.162 M | 55.600 M | 117.977 M | 182.476 M | 91.877 M | 71.396 M | 63.032 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 23.926 M | 23.812 M | 23.287 M | 24.404 M | 24.956 M | 22.046 M | 20.572 M | |
| Other Assets | 69.803 M | 65.090 M | 63.426 M | 61.218 M | 139.442 M | 131.560 M | 140.868 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 311.383 M | 259.705 M | 332.784 M | 297.508 M | 328.163 M | 385.012 M | 342.733 M | |
| Total liabilities | 67.617 M | 63.116 M | 143.280 M | 144.359 M | 221.239 M | 223.191 M | 221.865 M | |
| Total current liabilities | 24.441 M | 20.749 M | 37.877 M | 37.961 M | 34.288 M | 35.019 M | 37.448 M | |
| Accounts Payable | 10.078 M | 4.638 M | 5.429 M | 11.351 M | 10.025 M | 9.354 M | 8.887 M | |
| Other liabilities | 43.042 M | 42.367 M | 42.764 M | 43.180 M | 126.293 M | 128.421 M | 126.290 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 43.042 M | 42.367 M | 42.764 M | 43.180 M | 126.293 M | 128.421 M | 126.290 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 243.766 M | 196.589 M | 189.504 M | 153.149 M | 106.924 M | 161.821 M | 120.868 M | |
| Common stock | 780.952 M | 789.078 M | 834.419 M | 840.360 M | 846.041 M | 1.004 B | 1.009 B | |
| Retained earnings | -537.091 M | -592.418 M | -644.936 M | -687.212 M | -739.102 M | -842.275 M | -888.354 M |